Analysis of Human Dopamine D3 Receptor Quaternary Structure

被引:18
|
作者
Marsango, Sara [1 ]
Caltabiano, Gianluigi [2 ]
Pou, Chantevy [1 ]
Varela Liste, Mara Jose [1 ]
Milligan, Graeme [1 ]
机构
[1] Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain
基金
英国医学研究理事会;
关键词
PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; OLIGOMERIC ORGANIZATION; OPIOID RECEPTOR; INTERFACE; COMPLEX; GPCR; DIMERIZATION; COOPERATIVITY; EXPRESSION;
D O I
10.1074/jbc.M114.630681
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dopamine D-3 receptor is a class A, rhodopsin-like G protein-coupled receptor that can form dimers and/or higher order oligomers. However, the molecular basis for production of these complexes is not well defined. Using combinations of molecular modeling, site-directed mutagenesis, and homogenous time-resolved FRET, the interfaces that allow dopamine D-3 receptor monomers to interact were defined and used to describe likely quaternary arrangements of the receptor. These were then compared with published crystal structures of dimeric beta(1)-adrenoreceptor, beta-opioid, and CXCR4 receptors. The data indicate important contributions of residues from within each of transmembrane domains I, II, IV, V, VI, and VII as well as the intracellular helix VIII in the formation of D-3-D-3 receptor interfaces within homo-oligomers and are consistent with the D-3 receptor adopting a beta(1)-adrenoreceptor-like quaternary arrangement. Specifically, results suggest that D-3 protomers can interact with each other via at least two distinct interfaces: the first one comprising residues from transmembrane domains I and II along with those from helix VIII and a second one involving transmembrane domains IV and V. Moreover, rather than existing only as distinct dimeric species, the results are consistent with the D-3 receptor also assuming a quaternary structure in which two transmembrane domain I-II-helix VIII dimers interact to form a "rhombic" tetramer via an interface involving residues from transmembrane domains VI and VII. In addition, the results also provide insights into the potential contribution of molecules of cholesterol to the overall organization and potential stability of the D-3 receptor and possibly other GPCR quaternary structures.
引用
收藏
页码:15146 / 15162
页数:17
相关论文
共 50 条
  • [1] Structure-function relationships at human D3 dopamine receptor
    Sartania, N
    Strange, PG
    [J]. FASEB JOURNAL, 1997, 11 (09): : A919 - A919
  • [2] Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
    Chien, Ellen Y. T.
    Liu, Wei
    Zhao, Qiang
    Katritch, Vsevolod
    Han, Gye Won
    Hanson, Michael A.
    Shi, Lei
    Newman, Amy Hauck
    Javitch, Jonathan A.
    Cherezov, Vadim
    Stevens, Raymond C.
    [J]. SCIENCE, 2010, 330 (6007) : 1091 - 1095
  • [3] Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor
    Wood, MD
    Boyfield, I
    Nash, DJ
    Jewitt, FR
    Avenell, KY
    Riley, GJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 407 (1-2) : 47 - 51
  • [4] The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
    Wicke, K
    Garcia-Ladona, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (02) : 85 - 90
  • [5] A Molecular Basis for Selective Antagonist Destabilization of Dopamine D3 Receptor Quaternary Organization
    Marsango, Sara
    Caltabiano, Gianluigi
    Jimemez-Roses, Mireia
    Millan, Mark J.
    Pediani, John D.
    Ward, Richard J.
    Milligan, Graeme
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [6] A Molecular Basis for Selective Antagonist Destabilization of Dopamine D3 Receptor Quaternary Organization
    Sara Marsango
    Gianluigi Caltabiano
    Mireia Jiménez-Rosés
    Mark J. Millan
    John D. Pediani
    Richard J. Ward
    Graeme Milligan
    [J]. Scientific Reports, 7
  • [7] Structure-Based Drug Design for Dopamine D3 Receptor
    Feng, Zhiwei
    Hou, Tingjun
    Li, Youyong
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2012, 15 (10) : 775 - 791
  • [8] Structures of the human dopamine D3 receptor-Gi complexes
    Xu, Peiyu
    Huang, Sijie
    Mao, Chunyou
    Krumm, Brian E.
    Zhou, X. Edward
    Tan, Yangxia
    Huang, Xi-Ping
    Liu, Yongfeng
    Shen, Dan-Dan
    Jiang, Yi
    Yu, Xuekui
    Jiang, Hualiang
    Melcher, Karsten
    Roth, Bryan L.
    Cheng, Xi
    Zhang, Yan
    Xu, H. Eric
    [J]. MOLECULAR CELL, 2021, 81 (06) : 1147 - +
  • [9] D3 dopamine receptor mRNA is widely expressed in the human brain
    Suzuki, M
    Hurd, YL
    Sokoloff, P
    Schwartz, JC
    Sedvall, G
    [J]. BRAIN RESEARCH, 1998, 779 (1-2) : 58 - 74
  • [10] Identification and characterization of novel properties of the human D3 dopamine receptor
    Kuzhikandathil, EV
    Westrich, L
    Bakhos, S
    Pasuit, J
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 26 (01) : 144 - 155